Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ablynx Adds Sanofi To Its List Of Big Pharma Partners

Executive Summary

Sanofi is the latest big pharma, following on from Merck & Co., AbbVie and others, to team up with Belgian Nanobody drug developer Ablynx.

Advertisement

Related Content

Ablynx, Bioverativ Buys Drive Sanofi's Hematology Reign
Novo Outbid As Sanofi Agrees €3.9bn Ablynx Acquisition
Ablynx Ups Profile Stateside With $200m Nasdaq Listing
Caterpillar To Butterfly? Ablynx Says Caplacizumab Data Transformational
Deal Watch: Valeant Continues Divestment Spree By Selling Obagi At A Loss

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099171

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel